Video Latest - ecancer

Transplantation and short telomeres increase the risk of cognitive impairment

Dr Smita Bhatia - City of Hope National Medical Center, Duarte, California

8 Dec 2013

Donor-derived anti-CD19 chimeric-antigen-receptor-expressing T cells cause regression of malignancy

Dr James Kochenderfer - National Cancer Institute, Bethesda, USA

7 Dec 2013

Encouraging outcomes in older patients following nonmyeloablative haploidentical blood or marrow transplantation

Dr Yvette Kasamon - Johns Hopkins Kimmel Cancer Center, Baltimore, USA

7 Dec 2013

Cancer cells and the immune system: a natural story?

Prof. Laurence Zitvogel - INSERM, Institut Gustave Roussy, Villejuif, France

3 Dec 2013

Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction

Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The Netherlands

3 Dec 2013

Immuno-Oncology: a concept or already a reality?

Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK

3 Dec 2013

Why are Immuno-Oncology compounds different?

Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain

3 Dec 2013

Lgr5 stem cells in self-renewal and cancer

Dr Hans Clevers - Hubrecht Institute, Utrecht, Netherlands

3 Oct 2013

ecancermedicalscience Editor's Choice for October 2013

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

25 Sep 2013

ECC 2013 Preview: Scientific programme highlights

Prof Vincenzo Valentini and Ian Banks

11 Jul 2013

Use of autologous stem cell transplant in multiple myeloma

Dr Elena Zamagni - Bologna University School of Medicine, Bologna, Italy

19 Jun 2013

Daratumumab, a CD38 monoclonal antibody study in advanced multiple myeloma

Prof Heinrich Lokhorst - Universitair Medisch Centrum Utrecht, Heidelberglaan, Netherlands

17 Jun 2013

Video